← Leaderboards
John Michael Maslowski
Fibrocell Technologies, Inc.
$1,047,297
Attributed
$1,047,297
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $350K · FY2018–20$500K$375K$250K$125K$0
'18
'19
'20
Funding mix
By agency
FDA$1,047,297 · 1
By mechanism
R01$1,047,297 · 1
Top collaborators
No co-investigators on record.
Grant awards (3)
Ph1/2 Study of FCX-007 for Treatment of RDEB IND 16582 Protocolv4.1 (11/23/2016)$350,000
R01 · FY2020 · FD · contact PI
Ph1/2 Study of FCX-007 for Treatment of RDEB IND 16582 Protocolv4.1 (11/23/2016)$350,000
R01 · FY2019 · FD · contact PI
Ph1/2 Study of FCX-007 for Treatment of RDEB IND 16582 Protocolv4.1 (11/23/2016)$347,297
R01 · FY2018 · FD · contact PI